Antiremodelling Efficacy and Clinical Safety of Zofenopril in Patients with Grade 1and 2 Hypertension
Gulnoz KhamidullaevaThe Republican Specialized Center of Cardiology, Tashkent, UzbekistanTashkent, UzbekistanThe Republican Specialized Center of Cardiology, Tashkent, UzbekistanGuzal AbdullaevaThe Republican Specialized Center of Cardiology, Tashkent, UzbekistanLola KhafizovaThe Republican Specialized Center of Cardiology, Tashkent, UzbekistanNigora SrojidinovaThe Republican Specialized Center of Cardiology, Tashkent, UzbekistanNigora TursunovaThe Republican Specialized Center of Cardiology, Tashkent, UzbekistanDilorom KurbanovaNodira Shakirova
ABI
Annotatsiya
Objective: to estimate the antihypertensive, antiremodelling efficacy and clinical tolerability of the monotherapy with Zofenopril in patients with Grade 1 and 2 hypertension (HT 1 and 2)
Hali tarjima qilinmagan
Mavzular
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos9 ta foydalanilgan manba
Koʻrsatkichlar — AkademScholar · Tez orada